Challenges of CRISPR/Cas-Based Cell Therapy for Type 1 Diabetes: How Not to Engineer a "Trojan Horse".

Autor: Karpov, Dmitry S.1 (AUTHOR) aleom@yandex.ru, Sosnovtseva, Anastasiia O.1 (AUTHOR) sollomia@yandex.ru, Pylina, Svetlana V.2 (AUTHOR) pylina@icloud.com, Bastrich, Asya N.2 (AUTHOR) asjaha@gmail.com, Petrova, Darya A.2 (AUTHOR) darya0813@mail.ru, Kovalev, Maxim A.1 (AUTHOR) kovalev_maksim_2002@mail.ru, Shuvalova, Anastasija I.1 (AUTHOR) anastasiashuvalova777@gmail.com, Eremkina, Anna K.2 (AUTHOR) eremkina.anna@endocrincentr.ru, Mokrysheva, Natalia G.2 (AUTHOR) mokrisheva.natalia@endocrincentr.ru
Zdroj: International Journal of Molecular Sciences. Dec2023, Vol. 24 Issue 24, p17320. 33p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje